-
Innovative drugs and traditional Chinese medicine concept stocks continue to strengthen, and many stocks rose to the limit on January 16!
Time of Update: 2023-02-01
On the news, Hengrui Pharmaceutical issued an announcement on the evening of January 15 that the company recently received the "Drug Registration Certificate" of cyclophosphamide capsules approved and issued by the State Food and Drug Administration.
-
The number of lung CT examinations has surged, and related concept stocks have attracted the attention of the industry
Time of Update: 2023-02-01
It is reported that in order to reduce the pressure on major hospitals, United Imaging Medical is also accelerating the promotion of Tianyan CT into community hospitals.
-
The field of APIs has "turned over", and the performance of a large number of enterprises has increased significantly
Time of Update: 2023-02-01
【Pharmaceutical Network Market Analysis】 Recently, with the gradual liberalization of epidemic prevention and control, the pharmaceutical market has attracted much attention from the capital market, e
-
The traditional Chinese medicine sector will continue to strengthen, and the long-term development in these areas is also promising
Time of Update: 2023-02-01
In recent years, while continuously encouraging the innovation of traditional Chinese medicines and accelerating the review and approval, domestic policies are also further focusing on the quality, cl
-
In order to solve the development dilemma, the split and merger of pharmaceutical companies will become a "regular operation"
Time of Update: 2023-02-01
Not long ago, on December 19, 2022, Luye Pharmaceutical announced that Boan Biotech, a holding subsidiary and innovative biopharmaceutical company, entered the IPO stage and will be listed on the Hong Kong Stock Exchange.
-
On January 11, 17 pharmaceutical stocks in the two cities had block trading, and 3 of them had a turnover of more than 300 million yuan
Time of Update: 2023-02-01
In terms of average transaction price, the average transaction price of three stocks of Kaileying, BeiGene and Tigermed Pharma was more than 100 yuan, and the average transaction price of WuXi AppTec, Zhaoyan New Drug, Yifeng Pharmacy and Yunnan Baiyao exceeded 50 yuan.
-
How to improve the capacity of rural new crown severe disease treatment? Official response
Time of Update: 2023-02-01
3% from the peak 。 Jiao Yahui said that the detection rate of new crown positive infections in fever clinics also continued to decline, with a peak detection rate of 33.
-
The price of Chinese medicinal materials has skyrocketed, and the cost of raw materials of Sunflower Pharmaceutical has increased!
Time of Update: 2023-02-01
Fourth, children's lung heat cough and asthma oral liquid raw material market comment Ephedra, the origin of Inner Mongolia has recently taken normal goods, the production area is about to end processing, the New Year is approaching, merchants have also taken holidays for the New Year, and the logistics of the origin have been suspended.
-
The biological products sector was active, and 5 stocks such as Bailey Tianheng-U closed up more than 10% on January 13
Time of Update: 2023-02-01
According to the data, Baili Tianheng is a pharmaceutical stock listed on the Science and Technology Innovation Board on January 6, 2023, and the pharmaceutical company has a full range of drug research and development production capacity, including small molecule chemical drugs, large molecule biological drugs and antibody conjugate drugs (ADC drugs).
-
The "take medicine" market has returned? More than 200 pharmaceutical-themed funds achieved positive returns
Time of Update: 2023-02-01
According to Databao's statistics, in the past five trading days (December 29 to January 5), about 139 listed companies in Shanghai and Shenzhen have been investigated by institutions.
-
Announcement of the State Food and Drug Administration revising the instructions for Ibandronate sodium injection
Time of Update: 2023-02-01
According to the results of adverse drug reaction assessment, in order to further protect the safety of public medication, the State Medical Products Administration decided to uniformly revise the content of the instructions of Ibandronate sodium injection.
-
Medical beauty concept stocks collectively strengthened! Xingkerong Pharmaceutical soared 37%, and the blonde rabbi rose to the limit
Time of Update: 2023-02-01
【Pharmaceutical Network Pharmaceutical Stock Market】 On January 16, medical beauty concept stocks collectively strengthened, such as Xingkerong Pharmaceutical soared 37%, Jinfa Rabi rose to the limit, Aier Ophthalmology, Guangzheng Ophthalmology, Haohaisheng, Aimeike, Bloomage Biotechnology and a large number of other companies followed.
-
On January 9, the net outflow of pharmaceutical and biological funds exceeded 1.2 billion yuan, and 11 shares such as Tongrentang exceeded 50 million
Time of Update: 2023-02-01
52% of the circulating market value; In terms of securities financing, Kanglong Chemical repaid 260,800 shares on January 9, and sold 35,000 shares on margin trading, which was 2,519,700 yuan according to the closing price of the day, accounting for 0.
-
The accelerated development of traditional Chinese medicine in the direction of modernization also needs the help of the pharmaceutical machine industry
Time of Update: 2023-02-01
It is understood that at present, many domestic pharmaceutical equipment enterprises have actively invested in the transformation of automation, intelligence and informatization, strengthening technical research around the relevant links of traditional Chinese medicine manufacturing, and developing intelligent, networked, digital and new sets of traditional Chinese medicine pharmaceutical equipment and overall solutions in line with the concept of environmental protection to help the modernization process of traditional Chinese medicine.
-
APIs and pharmaceutical intermediates have changed in individual stocks, and many pharmaceutical companies have achieved a limit increase today
Time of Update: 2023-02-01
m. According to the data, the main business of East Asia Pharmaceutical is engaged in the research and development, production and sales of chemical APIs and pharmaceutical intermediates.
-
On the morning of January 6, biopharmaceutical stocks expanded, and Zai Lab rose by more than 40%, and many pharmaceutical companies followed suit
Time of Update: 2023-02-01
On January 6, Hong Kong biopharmaceutical stocks expanded, with Zai Lab up 40%, CanSino Biologics up 7%, minimally invasive robots-B up 1.
On January 6, Hong Kong biopharmaceutical stocks expanded, with Zai Lab up 40%, CanSino Biologics up 7%, minimally invasive robots-B up 1.
-
The State Food and Drug Administration released the 63rd batch of generic drug reference preparations
Time of Update: 2023-02-01
After the review and determination of the Expert Committee for the Consistency Evaluation of the Quality and Efficacy of Generic Drugs of the State Medical Products Administration, the list of refere
-
The popular rhubarb, how much room for growth in the future?
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];As a commonly used variety of bulk Chinese medicinal materials, the market of rhubarb in recent years can be described as rising, attracting widespread attention in the industry.
-
The pharmaceutical industry is accelerating the digital and intelligent transformation and upgrading, and "taking off" also needs the help of the pharmaceutical industry
Time of Update: 2023-02-01
China's pharmaceutical industry has basically ended its extensive development, accelerated its progress towards high quality, and entered a critical period of transformation from a "pharmaceutical pow
-
The eighth batch of centralized procurement of large varieties game: Pfizer and others compete for the 60 billion market!
Time of Update: 2023-02-01
Among the multinational original research enterprises, Pfizer, Sanofi, Merck, Lundbeck, AstraZeneca, Eisai and other enterprises are listed, of which Pfizer has the largest number of products, and 3 varieties are to be included, with cefoperazone sulbactam injection and voriconazole injection having a high market share.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
